Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Associations of proteomic age clocks with lifestyle risk factors, incident chronic diseases and mortality in two European cohorts.

Nature aging·2026

Same author

Associations of cortisol with Alzheimer's disease fluid and neuroimaging biomarkers: A systematic review.

Frontiers in neuroendocrinology·2026

Same author

Multi-View Biomedical Foundation Models for Molecule-Target and Property Prediction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross-Platform Validation.

Annals of clinical and translational neurology·2025

Same author

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.

Research square·2025

Same author

Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.

medRxiv : the preprint server for health sciences·2025

Same journal

Predicting Chemotherapy Response from Staging Laparoscopy Images.

medRxiv : the preprint server for health sciences·2026

Same journal

Development and External Validation of a Machine Learning Model for 10-Year Ischemic Stroke Risk Prediction in Diverse Populations.

medRxiv : the preprint server for health sciences·2026

Same journal

MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging Initiative.

medRxiv : the preprint server for health sciences·2026

Same journal

Genetic and maternal environmental contributions to estimated fetal weight at 20 weeks gestation compared with birthweight.

medRxiv : the preprint server for health sciences·2026

Same journal

Better immediate declarative memory is associated with forgetting during locomotor adaptation in chronic stroke and in older adults.

medRxiv : the preprint server for health sciences·2026

Same journal

An empirical Bayes framework for burden and dispersion association tests helps prioritize rare variants associated with Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

Foundational model aided automatic high-throughput drug screening using self-controlled cohort study.

Shenbo Xu¹, Raluca Cobzaru¹, Stan N Finkelstein¹

¹Institute for Data, Systems, and Society, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.

Medrxiv : the Preprint Server for Health Sciences

|August 16, 2024

Summary

This summary is machine-generated.

This study introduces an automated high-throughput drug screening workflow using large language models and electronic health records to identify potential drug repurposing candidates and adverse drug reactions efficiently.

Keywords:

drug repurposing drug screening incidence rate ratio natural language processing pharmacovigilance self-controlled cohort study

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jun 16, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

Computational biology and bioinformatics
Pharmacoepidemiology
Artificial intelligence in healthcare

Background:

Drug development and pharmacovigilance are costly and time-consuming.
Large-scale healthcare data and large language models (LLMs) offer new opportunities for drug screening.
Automated high-throughput screening can accelerate drug repurposing and adverse drug reaction detection.

Purpose of the Study:

To demonstrate a general workflow for automatic high-throughput drug screening.
To estimate associations between various exposures and diseases.
To integrate drug repurposing and pharmacovigilance, parse prescription lengths, and remove confounding relationships using LLMs.

Main Methods:

Utilized a self-controlled cohort study design on electronic health records (EHR).
Parsed prescription lengths from clinical texts and defined exposure/control periods.
Employed bioinformatic mapping and ChatGPT to remove confounding drug-disease relationships.

Main Results:

Assessed 3,444 medications across 276 diseases in 6,613,198 patients.
Identified 16,901 drug-disease pairs as potential repurposing candidates (risk reduction).
Identified 11,089 drug-disease pairs indicating potential safety concerns (risk increase).

Conclusions:

Developed a data-driven, automated workflow for hypothesis generation in pharmacoepidemiology.
Demonstrated the potential of natural language processing (NLP) for discovering novel therapies and adverse drug effects.
The framework is adaptable to other observational medical databases.